Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
She said that she had no smell, no taste, and no balance after taking them; She said that she had no smell, no taste, and no balance after taking them; She said that she had no smell, no taste, and no balance after taking them; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "multiple sclerosis" (unspecified if ongoing); "cholesterol abnormal" (unspecified if ongoing). Concomitant medication(s) included: COLESTID taken for blood cholesterol abnormal. The following information was reported: ANOSMIA (non-serious), AGEUSIA (non-serious), BALANCE DISORDER (non-serious), outcome "unknown" and all described as "She said that she had no smell, no taste, and no balance after taking them". Additional information: She was taking Colestid which was a medication for cholesterol. She took 2 packets of it every day then she was made to take these huge pills that she really has trouble swallowing. She also wanted to know if Pfizer had a program for Eliquis and Gemtesa where she could get them at a cheaper price. She further stated that she has multiple sclerosis, and she had to take three shots of the Pfizer COVID vaccine because she was in the (PRIVACY) and she could not get them to check her blood thinner without taking the shots. She said that she had no smell, no taste, and no balance after taking the Pfizer COVID vaccine. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Blood cholesterol abnormal; Multiple sclerosis
COLESTID